Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Trends in presentation, treatment and survival of 1777 patients with colorectal cancer over a decade: a Biobank study

Anu Carpelan; Heikki Minn; Eetu Heervä; Arto Rantala; Jari Sundström; Annika Ålgars; Olli Carpén; Raija Ristamäki; Samu Kurki; Heikki Huhtinen

Trends in presentation, treatment and survival of 1777 patients with colorectal cancer over a decade: a Biobank study

Anu Carpelan
Heikki Minn
Eetu Heervä
Arto Rantala
Jari Sundström
Annika Ålgars
Olli Carpén
Raija Ristamäki
Samu Kurki
Heikki Huhtinen
Katso/Avaa
Publisher's version (1.266Mb)
Lataukset: 

Taylor & Francis
doi:10.1080/0284186X.2017.1420230
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042717581
Tiivistelmä

Background:
Most survival data in colorectal cancer (CRC) is derived from clinical
trials or register-based studies. Hospital Biobanks, linked with
hospital electronic records, could serve as a data-gathering method
based on consecutively collected tumor samples. The aim of this Biobank
study was to analyze survival of colorectal patients diagnosed and
treated in a single-center university hospital over a period of 12
years, and to evaluate factors contributing to outcome.

Material and methods:
A total of 1777 patients with CRC treated during 2001–2012 were
identified from the Auria Biobank, Turku, Finland. Longitudinal clinical
information was collected from various hospital electronic records and
date and cause of death obtained from Statistics Finland.

Results:
Cancer-specific, overall and disease-free survival was higher in
patients diagnosed during 2004–2008 as compared with patients diagnosed
in 2001–2003. Further improvement was not seen during years 2009–2012.
Potential factors contributing to the improvement were introduction of
multidisciplinary meetings, centralization of rectal cancer surgery, use
of adjuvant chemotherapy and systematic preoperative radiotherapy of
rectal cancer. The proportion of patients with stage I–IV CRC remained
similar over the study period, but a marked decrease in non-metastatic
rectal cancer with biopsy only (locally advanced disease) was observed.
In stage I–III rectal cancer, Cox multivariate analysis suggested age,
comorbidity, R1 resection, T staging and tumor grade as prognostic
factors. In colon cancer, prognostic factors were age, comorbidity,
gender and presence of lymph node metastases.

Conclusions:
Organizational changes in the treatment of CRC patients made since 2004
coincide with improved survival in CRC and a marked reduction in
locally advanced rectal cancers. The clinical presentation of CRC has
remained similar between 2001 and 2012.

Kokoelmat
  • Rinnakkaistallenteet [19207]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste